Invited Speakers
Shrikant Anant University of Kansas Medical Center (USA)
Danny Dhanasekaran University of Oklahoma Health Sciences Center (USA)
Marc Diederich Seoul National University (Korea)
John DiGiovanni University of Texas at Austin (USA)
Zigang Dong University of Minnesota (USA)
Richard L. Eckert University of Maryland School of Medicine (USA)
Lothar Hennighausen National Institute of Health (USA)
Ciro Isidoro Università del Piemonte Orientale (Italy)
Li Li Ji University of Minnesota Twin Cities (USA)
Hee Seung Kim Seoul National University College of Medicine (Korea)
Seong-Jin Kim AICT, Seoul National University (Korea)
Yong Li St. George Hospital, University of New South Wales Sydney (Australia)
Kangdong Liu Zhengzhou University/China-US(Henan)Hormel Cancer Institute (China)
Massoud Mirshahi University Paris Diderot (France)
Taesung Park Seoul National University (Korea)
Woong-Yang Park Samsung Genome Institute (Korea)
Pradeep Chaluvally-Raghavan Medical College of Wisconsin (USA)
Yong Sang Song Seoul National University (Korea)
Gloria H. Su Columbia University Irving Medical Center (USA)
Young-Joon Surh Seoul National University (Korea)
Takemi Tanaka University of Oklahoma Health Sciences Center (USA)
Benjamin K. Tsang University of Ottawa (Canada)
Chin-Kun Wang Chung Shan Medical University (Taiwan)
Zhizhuang Joe Zhao University of Oklahoma Health Sciences Center (USA)
Speakers
Shrikant Anant University of Kansas Medical Center (USA)
Day 2, 9:50 - 10:10Session V: Cancer Stem Cells
Cancer Stem Cell Metabolism and Potential Therapeutic Targets
Shu Jen Chen ACT Genomics Co. ltd. (Taiwan)
Day 3, 14:40 - 15:10Sponsored Session by ACT Genomics Co. ltd.
Clinical implementation of cancer genome medicine
Yataro Daigo Shiga University of Medical Science / The University of Tokyo (Japan)
Day 3, 9:40-10:00Session Ⅸ: Omics in Various Cancers
Molecular analysis of tumor immune microenvironment in lung cancer
Danny Dhanasekaran University of Oklahoma Health Sciences Center (USA)
Day 2, 13:00-13:20Session Ⅵ: PCM Infrastructure
PCM Initiative: Global Consortium Ratinake and Strategies
Marc F. Diederich Seoul National University (Korea)
Day 2, 17:00-17:20Session Ⅷ: Cancer Metabolism, Nutrition and Aging
Cardiac glycosides as inducers of senescence and senolytic cell death
John DiGiovanni University of Texas at Austin (USA)
Day 1, 16:50-17:10Session IV : Cutting-edge Talks in Molecular Target Therapy of PCM
Targeting Metabolic and Antioxidant Pathways for Cancer Prevention and Treatment
Zigang Dong University of Minnesota (USA)
Day 2, 13:40-14:00Session Ⅵ: PCM Infrastructure
Integrative analysis of multi-omics data for PCM in China
Richard L. Eckert University of Maryland School of Medicine (USA)
Day 2, 10:10-10:30Session V: Cancer Stem Cells
Cancer Stem Cell-Enriched Proteins As Tumor Growth Factors and Therapy Targets
Masashi Fujita RIKEN (Japan)
Day 1, 15:10-15:30Session III : Cancer Immunotherapy and Genomics
Immuno-genomic profiling of liver cancer
Yoichi Furukawa Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo (Japan)
Day 2, 16:40-17:00Session Ⅶ: Genomic Medicine in PCM
Clinical implementation of AI-based cancer therapeutics
Noriko Goto Division of Cancer Cell Biology, Cancer Research Institute, Kanazawa University (Japan)
Day 2, 9:30-9:50Session V: Cancer Stem Cells
MCM10 maintains breast cancer stem-like cells by reducing Myc-dependent replication stress
Ryuji Hamamoto Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute (Japan)
Day 1, 11:40-12:00Session I: GWAS & Big Data Science
Development of the integrated cancer medical system using AI: Towards the realization of PCM
Lothar Hennighausen National Institute of Health (USA)
Day 2, 9:10-9:30Session V: Cancer Stem Cells
Genome editing and cancer
Akira Hirasawa Okayama University (Japan)
Day 3, 13:20-13:40Session Ⅺ: Implementation of Precision Cancer Genomics Medicine (CGM)
Hereditary tumors and PCM
Sadakatsu Ikeda Tokyo Medical and Dental University (TMDU) (Japan)
Day 2, 16:20-16:40Session Ⅶ: Genomic Medicine in PCM
Implementation of oncogene-panel and liquid-biopsy for PCM in TMDU
Day 3, 15:30-15:50
Sponsored Session by ACT Genomics Co. ltd.
The utility of cancer gene panel and liquid biopsy in the clinical setting
Seiya Imoto Division of Health Medical Data Science, Health Intelligence Center, Institute of Medical Science, The University of Tokyo (Japan)
Day 3, 13:40-14:00Session Ⅺ: Implementation of Precision Cancer Genomics Medicine (CGM)
Metagenome: Paradigm shift in health/medical care
Johji Inazawa Tokyo Medical and Dental University (TMDU) (Japan)
Day 2, 14:20-14:40Session Ⅵ: PCM Infrastructure
Integrative analysis of multi-omics data for PCM in TMDU
Jun Inoue Tokyo Medical and Dental University (TMDU) (Japan)
Day 3, 13:00-13:20Session Ⅺ: Implementation of Precision Cancer Genomics Medicine (CGM)
Therapeutic potential of miR-634 formulation for cancer therapy
Ciro Isidoro Università del Piemonte Orientale (Italy)
Day 2, 14:00-14:20Session Ⅵ: PCM Infrastructure
Integrative analysis of multi-omics data for PCM in Italy
Shumpei Ishikawa Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo (Japan)
Day 1, 14:30-14:50Session III: Cancer Immunotherapy and Genomics
Genetic and life-style factors for Asian gastric cancer
Li Li Ji University of Minnesota Twin Cities (USA)
Day 2, 18:00-18:20Session Ⅷ: Cancer Metabolism, Nutrition and Aging
Acetylation status and sarcopenia
Yoichiro Kamatani Laboratory of Complex Trait Genomics, Department of Computational biology and medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo (Japan)
Day 1, 11:20-11:40Session I: GWAS & Big Data Science
The insights from multiple GWAS of Japanese population
Toyomasa Katagiri Division of Genome Medicine, Institute of Advanced Medical Sciences, Tokushima University (Japan)
Day 3, 9:20-9:40Session Ⅸ: Omics in Various Cancers
Novel therapeutic strategy for breast cancer utilizing tumor suppressor activity
Hee Seung Kim Seoul National University College of Medicine (Korea)
Day 2, 15:40-16:00Session Ⅶ: Genomic Medicine in PCM
Diagnosis and treatment based on PCM using genomics and proteomics in gynecologic cancers
Seong-Jin Kim AICT, Seoul National University (Korea)
Day 1, 16:30-16:50Session IV: Cutting-edge Talks in Molecular Target Therapy of PCM
Vactosertib, a TGF-β receptor I kinase inhibitor, has shown significant preclinical and clinical antitumor efficacy
Kenneth Kinzler Professor of Oncology,Associate Director for Laboratory Research, SKCCC Director, Ludwig Center at Johns Hopkins University (USA)
Day 2, 10:40-11:30Plenary Lecture sponsored by SYSMEX
Liquid Biopsies for Earlier Cancer Detection
Kazuma Kiyotani Cancer Precision Medicine Center, Japanese Foundation for Cancer Research (Japan)
Day 1, 15:30-15:50Session III: Cancer Immunotherapy and Genomics
Prediction and screening of neoantigen-specific T cells
Yutaka Kondo Division of Cancer Biology, Nagoya University Graduate School of Medicine (Japan)
Day 1, 17:30-17:50Session IV: Cutting-edge Talks in Molecular Target Therapy of PCM
Roles of TUG1 in Regulation of DNA Replication Stress in Cancer Cells
Yong Li St. George Hospital, University of New South Wales Sydney (Australia)
Day 1, 13:10-13:30Session II: Liquid Biopsy/Exosome/Biomarkers
Exosomes as liquid biomarkers for prostate cancer early diagnosis and progress monitoring
Kangdong Liu Zhengzhou University/China-US(Henan)Hormel Cancer Institute (China)
Day 3, 11:20-11:40Session Ⅹ: New Targets for Cancer Therapeutics
Proteome and phosphoproteome reveal the mechanisms of chemopropreventive drugs against esophageal cancer
Siew Kee Low Japanese Foundation for Cancer Research (Japan)
Day 1, 13:30-13:50Session II: Liquid Biopsy/Exosome/Biomarkers
NGS of circulating tumor DNA in clinical cancer research
Koichi Matsuda Laboratory of Clinical Genome Sequencing, Department of Computational biology and medical Sciences, Graduate school of Frontier Sciences, The University of Tokyo (Japan)
Day 1, 10:40-11:00Session I: GWAS & Big Data Science
Genome analysis of musculoskeletal tumors
Massoud Mirshahi University Paris Diderot (France)
Day 3, 9:00-9:20Session Ⅸ: Omics in Various Cancers
Differentiation therapy helps cancer cell evade immunity via up regulation of HLA-G and PD-L1.
Satoru Miyano Human Genome Center, The Institute of Medical Science, The University of Tokyo (Japan)
Day 1, 10:10-10:40Keynote Address Ⅰ
Medical Big Data Science
Kaori Muto Department of Public Policy, The Institute of Medical Science, The University of Tokyo (Japan)
Day 3, 14:00-14:20Session Ⅺ: Implementation of Precision Cancer Genomics Medicine (CGM)
Ethical problems in PCM
Hiroki Nagase Chiba Cancer Center Research Institute (Japan)
Day 3, 10:40-11:00Session Ⅹ: New Targets for Cancer Therapeutics
Drug discovery targeting genome DNA by using Pyrrole-Imidazole polyamide-drug conjugates
Yusuke Nakamura Japanese Foundation for Cancer Research (Japan)
Day 2, 15:00-15:40Keynote Address Ⅱ
Immunogenomics and Immunotherapy
Katsutoshi Oda Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo (Japan)
Day 2, 16:00-16:20Session Ⅶ: Genomic Medicine in PCM
Implementation of Todai OncoPanel for PCM in U-Tokyo
Taku Okazaki Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo (Japan)
Day 1, 16:10-16:30Session IV : Cutting-edge Talks in Molecular Target Therapy of PCM
Regulation of autoimmunity and anti-cancer immunity by immuno-inhibitory co-receptors
Taesung Park Seoul National University (Korea)
Day 1, 11:00-11:20Session I: GWAS & Big Data Science
Hierarchical structural component analysis for multi-omics data
Woong-Yang Park Samsung Genome Institute (Korea)
Day 1, 14:50-15:10Session III : Cancer Immunotherapy and Genomics
Single cell seq in gastric cancer
Pradeep Chaluvally-Raghavan Medical College of Wisconsin (USA)
Day 3, 11:00-11:20Session Ⅹ: New Targets for Cancer Therapeutics
Unexpected Role of Mature miRNAs in Nucleus for Transcriptional activation
Yong Sang Song Seoul National University (Korea)
Day 2, 13:20-13:40Session Ⅵ: PCM Infrastructure
Innovative platform for precision cancer medicine in ovarian cancer
Gloria H. Su Columbia University Irving Medical Center (USA)
Day 3, 8:40-9:00Session Ⅸ: Omics in Various Cancers
Pancreatic cancer precision medicine
Young-Joon Surh Seoul National University (Korea)
Day 2, 17:20-17:40Session Ⅷ: Cancer Metabolism, Nutrition and Aging
Role of Nrf2-induced reductive stress in self-renewal of breast cancer stem-like cells
Akira Takemoto Tokyo Medical and Dental University (TMDU) (Japan)
Day 3, 15:10-15:30Sponsored Session by ACT Genomics Co. ltd.
TMDU Biobank project and its contribution to precision cancer medicine (PCM)
Benjamin K. Tsang University of Ottawa (Canada)
Day 1, 14:10-14:30Session II: Liquid Biopsy/Exosome/Biomarkers
Ovarian Cancer in an Era of Precision Medicine : From Cellular Mechanisms to Early diagnosis to Predictive Treatment Outcome
Koji Ueda Japanese Foundation for Cancer Research (Japan)
Day 1, 13:50-14:10Session II: Liquid Biopsy/Exosome/Biomarkers
Proteogenomic profiling of HLA-presented antigens toward cancer precision medicine
Chin-Kun Wang Chung Shan Medical University (Taiwan)
Day 2, 17:40-18:00Session Ⅷ: Cancer Metabolism, Nutrition and Aging
Anti-cancer and metabolism in precision cancer medicine (PCM)
Tetsuro Watabe Department of Biochemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU) (Japan)
Day 3, 10:00-10:20Session Ⅸ: Omics in Various Cancers
Roles of TGF-β family signals during progression of oral cancer
Zhizhuang Joe Zhao University of Oklahoma Health Sciences Center (USA)
Day 1, 17:10-17:30Session IV : Cutting-edge Talks in Molecular Target Therapy of PCM
Treating acute myeloid leukemia by targeting FLT3 using FLT3 ligand-containing chimeric antigen receptor
Day 1 (Mar.2)March 2 (Mon.)
| Time | Events |
|---|---|
| 9:00 - 10:00 | Registration TMDU M&D Tower 2F Akio Suzuki Memorial Hall |
| 10:00 - 10:05 | Opening Remark 1 Johji Inazawa (Tokyo Medical and Dental University) |
| 10:05 - 10:10 | Opening Remark 2 Yong Sang Song (Seoul National University) |
| Open Session | Keynote Address Ⅰ Chair: Yong Sang Song (Seoul National University) |
| 10:10 - 10:40 | Medical Big Data Science
Satoru Miyano (The University of Tokyo) |
| Session I | Session I: GWAS & Big Data Science Chairs: Taesung Park (Seoul National University), Masaki Muramatsu (Tokyo Medical and Dental University) |
| 10:40 - 11:00 | Genome analysis of musculoskeletal tumors Koichi Matsuda (The University of Tokyo) |
| 11:00 - 11:20 | Hierarchical structural component analysis for multi-omics data
Taesung Park (Seoul National University) |
| 11:20 - 11:40 | The insights from multiple GWAS of Japanese population
Yoichiro Kamatani (The University of Tokyo) |
| 11:40 - 12:00 | Development of the integrated cancer medical system using AI: Towards the realization of PCM
Ryuji Hamamoto (Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute) |
Technical Seminar Ⅰ | Technical Seminar Ⅰ |
| 12:00 - 13:00 | A- Illumina B- NanoString Technologies, Inc. |
| Session II | Session II : Liquid Biopsy/Exosome/Biomarkers Chairs: Satoshi Nagayama (Japanese Foundation for Cancer Research), Ciro Isidoro (Università del Piemonte Orientale) |
| 13:10 - 13:30 | Exosomes as liquid biomarkers for prostate cancer early diagnosis and progress monitoring
Yong Li (University of New South Wales) |
| 13:30 - 13:50 | NGS of circulating tumor DNA in clinical cancer research
Siew Kee Low (Japanese Foundation for Cancer Research) |
| 13:50 - 14:10 | Proteogenomic profiling of HLA-presented antigens toward cancer precision medicine
Koji Ueda (Japanese Foundation for Cancer Research) |
| 14:10 - 14:30 | Ovarian Cancer in an Era of Precision Medicine : From Cellular Mechanisms to Early diagnosis to Predictive Treatment Outcome
Benjamin K. Tsang (University of Ottawa) |
| Session III | Session III : Cancer Immunotherapy and Genomics Chairs: John DiGiovanni (University of Texas at Austin), Seong Jin Kim (AICT, Seoul National University) |
| 14:30 - 14:50 | Genetic and life-style factors for Asian gastric cancer
Shumpei Ishikawa (The University of Tokyo) |
| 14:50 - 15:10 | Single cell seq in gastric cancer
Woong Yang Park (Samsung Genome Institute) |
| 15:10 - 15:30 | Immuno-genomic profiling of liver cancer
Masashi Fujita (RIKEN) |
| 15:30 - 15:50 | Prediction and screening of neoantigen-specific T cells
Kazuma Kiyotani (Japanese Foundation for Cancer Research) |
| 15:50 - 16:10 | Coffee break |
| Session IV | Session IV : Cutting-edge Talks in Molecular Target Therapy of PCM Chairs: Shrikant Anant (University of Kansas Medical Center), Woong-Yang Park (Samsung Genome Institute) |
| 16:10 - 16:30 | Regulation of autoimmunity and anti-cancer immunity by immuno-inhibitory co-receptors
Taku Okazaki (The University of Tokyo) |
| 16:30 - 16:50 | Vactosertib, a TGF-β receptor I kinase inhibitor, has shown significant preclinical and clinical antitumor efficacy
Seong Jin Kim (AICT, Seoul National University) |
| 16:50 - 17:10 | Targeting Metabolic and Antioxidant Pathways for Cancer Prevention and Treatment
John DiGiovanni (University of Texas at Austin) |
| 17:10 - 17:30 | Treating acute myeloid leukemia by targeting FLT3 using FLT3 ligand-containing chimeric antigen receptor
Zhizhuang Joe Zhao (University of Oklahoma Health Sciences Center) |
| 17:30 - 17:50 | Roles of TUG1 in Regulation of DNA Replication Stress in Cancer Cells
Yutaka Kondo (Nagoya University) |
| 17:50 - 18:00 | Closing Remark & Photo Session
Johji Inazawa (Tokyo Medical and Dental University) |
| Mixer | Mixer on the 1st day (M&D Tower SKY lounge ) |
March 3 (Tue.)
| Time | Events |
|---|---|
| 8:30 - 9:00 | Registration TMDU M&D Tower 2F Akio Suzuki Memorial Hall |
| 9:00 - 9:10 | Opening Remark Johji Inazawa (Tokyo Medical and Dental University) |
| Session V | Session V: Cancer Stem Cells Chairs: Richard L. Eckert (University of Maryland School of Medicine), Tetsuya Taga (Tokyo Medical and Dental University) |
| 9:10 - 9:30 | Genome editing and cancer
Lothar Hennighausen (National Institute of Health) |
| 9:30 - 9:50 | MCM10 maintains breast cancer stem-like cells by reducing Myc-dependent replication stress
Noriko Goto (Kanazawa University) |
| 9:50 - 10:10 | Cancer Stem Cell Metabolism and Potential Therapeutic Targets
Shrikant Anant (University of Kansas Medical Center) |
| 10:10 - 10:30 | Cancer Stem Cell-Enriched Proteins As Tumor Growth Factors and Therapy Targets
Richard L Eckert (University of Maryland School of Medicine and Greenbaum Cancer Center) |
| Poster Session /Coffee Break | Poster Session/Coffee Break |
| 10:30 - 10:40 | Poster Session/Coffee Break |
| Plenary Lecture (Open Session) | Plenary Lecture sponsored by SYSMEX Chair: Takashi Tokino (Sapporo Medical University) |
| 10:40 - 11:30 | Liquid Biopsies for Earlier Cancer Detection
Kenneth Kinzler（Johns Hopkins University) |
Technical Seminar II | Technical Seminar II |
| 11:50 - 12:50 | A- Thermo Fisher Scientific
B- MGI JAPAN |
| Session Ⅵ | Session Ⅵ: Future Direction of PCM Chairs: Johji Inazawa (Tokyo Medical and Dental University), Danny Dhanasekaran (University of Oklahoma Health Sciences Center) |
| 13:00 - 13:20 | Coding and non-coding Transcriptomic Analysis in Ovarian Cancer
Danny Dhanasekaran (University of Oklahoma Health Sciences Center) |
| 13:20 - 13:40 | Innovative platform for precision cancer medicine in ovarian cancer
Yong Sang Song (Seoul National University) |
| 13:40 - 14:00 | Is WT1 Gene a Tumor Suppressor or Oncogene?
Zigang Dong (University of Minnesota) |
| 14:00 - 14:20 | Glucose Availability Promotes Cancer Cell Migration: Molecular Pathology and Epigenetic Regulation in PCM
Ciro Isidoro (Università del Piemonte Orientale) |
| 14:20 - 14:40 | microRNA Therapeutics in PCM
Johji Inazawa (Tokyo Medical and Dental University) |
| Poster Session /Coffee Break | Poster Session/Coffee Break |
| 14:40 - 15:00 | Poster Session/Coffee Break
TMDU M&D Tower 2F Foyer |
| Open Session | Keynote Address Ⅱ Chair: Akira Horii (Tohoku University School of Medicine) |
| 15:00 - 15:40 | Immunogenomics and Immunotherapy
Yusuke Nakamura (Japanese Foundation for Cancer Research) |
| Session Ⅶ | Session Ⅶ: Genomic Medicine in PCM Chairs: Lothar Hennighausen (National Institute of Health), Tatsuhiko Tsunoda (The University of Tokyo) |
| 15:40 - 16:00 | Diagnosis and treatment based on PCM using genomics and proteomics in gynecologic cancers
Hee Seung Kim (Seoul National University) |
| 16:00 - 16:20 | Implementation of Todai OncoPanel for PCM in U-Tokyo
Katsutoshi Oda (The University of Tokyo) |
| 16:20 - 16:40 | Implementation of oncogene-panel and liquid-biopsy for PCM in TMDU
Sadakatsu Ikeda (Tokyo Medical and Dental University, Cancer Center) |
| 16:40 - 17:00 | Clinical implementation of AI-based cancer therapeutics
Yoichi Furukawa (The University of Tokyo) |
| Session Ⅷ | Session Ⅷ: Cancer Metabolism, Nutrition and Aging Chairs: Young Joon Surh (Seoul National University), Hirofumi Arakawa (National Cancer Center Research Institute) |
| 17:00 - 17:20 | Cardiac glycosides as inducers of senescence and senolytic cell death
Marc F Diederich (Seoul National University) |
| 17:20 - 17:40 | Role of Nrf2-induced reductive stress in self-renewal of breast cancer stem-like cells
Young Joon Surh (Seoul National University) |
| 17:40 - 18:00 | Anti-cancer and metabolism in precision cancer medicine (PCM)
Chin-Kun Wang (Chung Shan Medical University) |
| 18:00 - 18:20 | Acetylation status and sarcopenia
Li Li Ji (University of Minnesota) |
| 18:20 | Closing Remark & Photo Session
Johji Inazawa (Tokyo Medical and Dental University) |
March 4 (Wed.)
| Time | Events | |
|---|---|---|
| 8:00 - 8:30 | Registration TMDU M&D Tower 2F Akio Suzuki Memorial Hall |
|
| 8:30 - 8:40 | Opening Remark Johji Inazawa (Tokyo Medical and Dental University) |
|
| Session Ⅸ | Session Ⅸ: Omics in Various Cancers Chairs: Zigang Dong (University of Minnesota), Tatsushi Toda (The University of Tokyo) |
|
| 8:40 - 9:00 | Pancreatic cancer precision medicine
Gloria H. Su (Columbia University) |
|
| 9:00 - 9:20 | Differentiation therapy helps cancer cell evade immunity via up regulation of HLA-G and PD-L1.
Massoud Mirshahi (University Paris Diderot) |
|
| 9:20 - 9:40 | Novel therapeutic strategy for breast cancer utilizing tumor suppressor activity
Toyomasa Katagiri（Tokushima Universiy) |
|
| 9:40 - 10:00 | Molecular analysis of tumor immune microenvironment in lung cancer
Yataro Daigo (Shiga University of Medical Science / The University of Tokyo) |
|
| 10:00 - 10:20 | Roles of TGF-β family signals during progression of oral cancer
Tetsuro Watabe (Tokyo Medical and Dental University) |
|
| Poster Session /Coffee Break | Poster Session/Coffee Break | |
| 10:20 - 10:40 | Poster Session/Coffee Break | |
| Session Ⅹ | Session Ⅹ: New Targets for Cancer Therapeutics Chairs: Gloria H. Su (Columbia University), Massoud Mirshahi (University Paris Diderot) |
|
| 10:40 - 11:00 | Drug discovery targeting genome DNA by using Pyrrole-Imidazole polyamide-drug conjugates
Hiroki Nagase (Chiba Cancer Center) |
|
| 11:00 - 11:20 | Unexpected Role of Mature miRNAs in Nucleus for Transcriptional activation
Pradeep Chaluvally-Raghavan (Medical College of Wisconsin) |
|
| 11:20 - 11:40 | Proteome and phosphoproteome reveal the mechanisms of chemopropreventive drugs against esophageal cancer
Kangdong Liu (Zhengzhou University) |
|
| 11:40 - 12:00 | TBA |
|
| Technical Seminar Ⅲ | Technical Seminar Ⅲ |
|
| 12:00 - 13:00 | ACTmed Co.,Ltd. | |
| Session Ⅺ | Session Ⅺ: Implementation of Precision Cancer Genomics Medicine (CGM) Chairs: Yoshio Miki (Tokyo Medical and Dental University), Takaaki Sato (University of Tsukuba) |
|
| 13:00 - 13:20 | Therapeutic potential of miR-634 formulation for cancer therapy
Jun Inoue (Tokyo Medical and Dental University) |
|
| 13:20 - 13:40 | Hereditary tumors and PCM
Akira Hirasawa (Okayama University) |
|
| 13:40 - 14:00 | Metagenome: Paradigm shift in health/medical care
Seiya Imoto（The University of Tokyo) |
|
| 14:00 - 14:20 | Ethical problems in PCM
Kaori Muto (The University of Tokyo) |
|
| Poster Session /Coffee Break | Poster Session/Coffee Break | |
| 14:20 - 14:40 | Poster Session/Coffee Break | |
| 14:40 - 15:50 | Open Session
Chair: Satoshi Miyake (Akio Suzuki Memorial Hall) |
Session B Chair: TBA (Kyouyoukougishitsu) |
| 15:50 | Closing Remark
Johji Inazawa (Tokyo Medical and Dental University) |
|
Open Session
| Open Session | Open satellite symposium: Comprehensive genomic profiling of tumor samples stored by TMDU BRC Chair: Satoshi Miyake (Tokyo Medical and Dental University) |
|---|---|
| 14:40 - 14:50 | Introduction of the collaborative program "Comprehensive genomic profiling of tumor samples stored by TMDU BRC"
Johji Inazawa (Tokyo Medical and Dental University) |
| 14:50 - 15:10 | Clinical implementation of cancer genome medicine
Shu Jen Chen（ACT Genomics Co. ltd.) |
| 15:10 - 15:30 | TMDU Biobank project and its contribution to precision cancer medicine (PCM)
Akira Takemoto (Tokyo Medical and Dental University, BRC) |
| 15:30 - 15:50 | The utility of cancer gene panel and liquid biopsy in the clinical setting
Sadakatsu Ikeda (Tokyo Medical and Dental University, Cancer Center) |
Session B
| Session B | Session B Chairs: TBA |
|
|---|---|---|
| 14:40 - 15:50 | TBA | |
